257 related articles for article (PubMed ID: 31733108)
1. A global epidemic increase of an HPV-induced tonsil and tongue base cancer - potential benefit from a pan-gender use of HPV vaccine.
Näsman A; Du J; Dalianis T
J Intern Med; 2020 Feb; 287(2):134-152. PubMed ID: 31733108
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus and tonsillar and base of tongue cancer.
Ramqvist T; Grün N; Dalianis T
Viruses; 2015 Mar; 7(3):1332-43. PubMed ID: 25803099
[TBL] [Abstract][Full Text] [Related]
3. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?
Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506
[TBL] [Abstract][Full Text] [Related]
4. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden.
Haeggblom L; Attoff T; Yu J; Holzhauser S; Vlastos A; Mirzae L; Ährlund-Richter A; Munck-Wikland E; Marklund L; Hammarstedt-Nordenvall L; Ye W; Ramqvist T; Näsman A; Dalianis T
Head Neck; 2019 Jun; 41(6):1583-1590. PubMed ID: 30584688
[TBL] [Abstract][Full Text] [Related]
5. ["Epidemic" increase of tonsillar and base of tongue cancer. Explanation: parallel increase of HPV infections].
Munck-Wikland E; Attner P; Näsman A; Hammerstedt L; Ramqvist T; Dalianis T
Lakartidningen; 2010 Jun 30-Jul 20; 107(26-28):1702-4. PubMed ID: 20701150
[No Abstract] [Full Text] [Related]
6. Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome.
Ramqvist T; Näsman A; Franzén B; Bersani C; Alexeyenko A; Becker S; Haeggblom L; Kolev A; Dalianis T; Munck-Wikland E
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587383
[TBL] [Abstract][Full Text] [Related]
7. Survival of patients with oropharyngeal squamous cell carcinomas (OPSCC) in relation to TNM 8 - Risk of incorrect downstaging of HPV-mediated non-tonsillar, non-base of tongue carcinomas.
Marklund L; Holzhauser S; de Flon C; Zupancic M; Landin D; Kolev A; Haeggblom L; Munck-Wikland E; Hammarstedt-Nordenvall L; Dalianis T; Näsman A
Eur J Cancer; 2020 Nov; 139():192-200. PubMed ID: 32951963
[TBL] [Abstract][Full Text] [Related]
8. Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3.
Bersani C; Sivars L; Haeggblom L; DiLorenzo S; Mints M; Ährlund-Richter A; Tertipis N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
Oncotarget; 2017 May; 8(21):35339-35350. PubMed ID: 28525363
[TBL] [Abstract][Full Text] [Related]
9. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.
Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A
Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus and survival of patients per histological subsite of tonsillar squamous cell carcinoma.
Haeggblom L; Attoff T; Hammarstedt-Nordenvall L; Näsman A
Cancer Med; 2018 May; 7(5):1717-1722. PubMed ID: 29573210
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review).
Dalianis T
Int J Oncol; 2014 Jun; 44(6):1799-805. PubMed ID: 24676623
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.
Marklund L; Näsman A; Ramqvist T; Dalianis T; Munck-Wikland E; Hammarstedt L
Cancer Med; 2012 Aug; 1(1):82-8. PubMed ID: 23342257
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of FGFR3 in HPV-positive Tonsillar and Base of Tongue Cancer Is Correlated to Outcome.
Bersani C; Haeggblom L; Ursu RG; Giusca SE; Marklund L; Ramqvist T; Näsman A; Dalianis T
Anticancer Res; 2018 Aug; 38(8):4683-4690. PubMed ID: 30061236
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) in Chinese oropharyngeal squamous cell carcinoma (OPSCC): A strong predilection for the tonsil.
Xu T; Shen C; Wei Y; Hu C; Wang Y; Xiang J; Sun GH; Su F; Wang Q; Lu X
Cancer Med; 2020 Sep; 9(18):6556-6564. PubMed ID: 32717137
[TBL] [Abstract][Full Text] [Related]
16. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014.
Carlander AF; Grønhøj Larsen C; Jensen DH; Garnæs E; Kiss K; Andersen L; Olsen CH; Franzmann M; Høgdall E; Kjær SK; Norrild B; Specht L; Andersen E; van Overeem Hansen T; Nielsen FC; von Buchwald C
Eur J Cancer; 2017 Jan; 70():75-82. PubMed ID: 27888679
[TBL] [Abstract][Full Text] [Related]
17. A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancer.
Tertipis N; Hammar U; Näsman A; Vlastos A; Nordfors C; Grün N; Ährlund-Richter A; Sivars L; Haeggblom L; Marklund L; Hammarstedt-Nordenvall L; Chaturvedi AK; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Aug; 51(12):1580-7. PubMed ID: 26025766
[TBL] [Abstract][Full Text] [Related]
18. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
[TBL] [Abstract][Full Text] [Related]
19. The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients.
Zamani M; Grønhøj C; Jensen DH; Carlander AF; Agander T; Kiss K; Olsen C; Baandrup L; Nielsen FC; Andersen E; Friborg J; von Buchwald C
Eur J Cancer; 2020 Jul; 134():52-59. PubMed ID: 32460181
[TBL] [Abstract][Full Text] [Related]
20. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
